Login / Signup

Rapamycin-Mediated mTOR Inhibition Reverses Drug Resistance to Adriamycin in Colon Cancer Cells.

Qiang MaZonghong ChangWei WangBiaomeng Wang
Published in: Hepato-gastroenterology (2016)
This study has indicated that the inhibition of the mTOR pathway reverses multidrug resistance in colorectal cancer cells, which is associated with increased autophagy, apoptosis and reduced mdr1 gene expression in drug-resistant cells treated with Adriamycin.
Keyphrases